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Phosphorylation of histone H3 at serine 10 (S10) is essential 
for the onset of mitosis. Here, we show that basal c-Jun N-terminal 
kinases (JNKs) are required for mitotic histone H3-S10 phos-
phorylation in human primary fibroblast IMR90 cells. Inhibition 
of JNKs by specific pharmacologic inhibitors, expression of 
dominant-negative JNK1 and 2 mutants, or RNAi of JNK1 and 
2 prevented phosphorylation of histone H3 at S10 in vivo. The 
JNK-specific inhibitor SP600125 blocked mitotic entry, as shown 
by its ability to prevent CDK1 dephosphorylation and cyclin A 
degradation. Basal JNK phosphorylation increased at G2/M phase, 
although total JNK protein levels remained unchanged. In addi-
tion, basal JNKs were localized in nuclei and centrosomes during 
this time, suggesting that the nuclear localization of JNKs during 
G2/M is tightly coupled with histone H3 phosphorylation. Basal 
JNKs were able to phosphorylate histone H3 in vitro and co-
precipitation of histone H3 and JNKs was only detected at G2/M. 
Taken together, these data strongly suggest that basal JNKs play 
a key role in controlling histone H3 phosphorylation for mitotic 
entry at G2/M phase.
Introduction
Histone H3 associated with condensed chromosomes has long 
been recognized to become globally phosphorylated at serine 10 
(S10) during mitosis. This phosphorylation of histone H3 has 
traditionally been regarded as a marker of mitosis.1,2 Histone H3-
S10 phosphorylation is involved in initiating, but not maintaining, 
mammalian chromosome condensation.1 Recent reports revealed 
that never in mitosis A (NIMA) kinase and aurora kinase regulate the 
phosphorylation of histone H3 at S10 to trigger mitosis (reviewed in 
refs. 3 and 4).
In contrast to the global histone H3 phosphorylation associ-
ated with mitosis, a more selective pattern of histone H3-S10 
phosphorylation is known to occur in response to various mitogens 
and stresses, and these stress-induced signaling pathways have been 
well documented.5 The transient phosphorylation of histone H3 
at S10 by mitogenic activation is closely related to the induction 
of immediate-early response genes, including the proto-oncogenes 
c-fos and c-jun.6,7 Several kinases have been shown to be involved 
in histone H3-S10 phosphorylation elicited by mitogens or various 
extracellular stresses. They include the mitogen-activated protein 
kinases (MAPKs), extracellular signal-regulated kinases (ERKs),7,8 
p38 kinases,8,9 stress-activated protein kinase 1 and 2 (MSK1 and 
MSK2),10 and ribosomal S6 kinase 2 (RSK2).11
C-Jun N-terminal kinases (JNKs) are members of MAPK family, 
well-known to be activated by diverse stresses. JNKs activated by 
extracellular stresses or inflammatory signals have been shown to 
phosphorylate histone H3 at S10, triggering transcriptional activa-
tion.7,12 JNKs have other functions apart from those related to 
cellular stress responses. For example, they have been shown to regu-
late mitosis and the proliferation of unstressed cells. In embryonic 
fibroblasts, inactivation of MKK7, the upstream activating kinase 
of JNK, induces G2/M cell cycle arrest and premature senescence, 
suggesting that MKK7-JNK signaling is directly responsible for 
the control of proliferation and cellular senescence (reviewed in 
refs. 13 and 14). Inhibition of JNKs using SP600125 or JNK1 and 
2 antisense also leads to mitotic cell cycle arrest in several cancer 
cell lines.15,16 However, the mechanisms by which JNKs modulate 
mitotic progression and cellular proliferation are not well under-
stood. In this study, we demonstrate that the basal JNK activation 
at G2/M transition mediates mitotic histone H3 phosphorylation at 
S10 to promote mitosis in primary fibroblast IMR90 cells.
Results
Selective inhibition of basal JNKs by SP600125 blocks cell 
proliferation and induces G2/M cell cycle arrest. To approach the 
function of JNKs in the regulation of cell cycle progression, we first 
tested whether the selective inhibition of JNKs affects cell growth 
and proliferation. We chose to perform these tests in IMR90 human 
primary fibroblast cells, since transformed cell lines with oncogenic 
and/or tumor suppressor mutations may contain altered JNK 
signaling pathways. The results with IMR90 were also confirmed 
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with mouse fibroblast NIH3T3 cells. Preliminary experiments with 
IMR90 and NIH3T3 cells revealed that a 72-hour incubation in 20 
μM of the selective JNK inhibitor SP600125 resulted in approxi-
mately 50% viability as measured by MTT assays (data not shown). 
Based on these results, we used this concentration and treatment 
time of SP600125 for the cell growth and proliferation experiments. 
No increase in cell number was observed in IMR90 cells treated 
with SP600125, while untreated control cells continuously prolif-
erated (Fig. 1A), demonstrating basal activity of JNKs is necessary 
for cell proliferation. This result was confirmed by examining cell 
proliferation in the presence of two other selective JNK inhibitors, 
JNK inhibitor I and JNK inhibitor III. IMR90 cells treated with 
each inhibitor also showed decreased cell proliferation (Fig. 1A). The 
function of basal JNKs for cell proliferation was further verified in 
cells where the expression of JNK1 and 2 was knocked downed by 
RNAi. Cell proliferation was reduced in IMR90 cells transfected 
with a combination of JNK1 and JNK2 RNAi duplex oligonucle-
otides and showed decreased JNK/SAPK expression, while cells 
transfected with control duplex proliferated continuously (Fig. 1B). 
These observations strongly support that the basal activity of JNKs is 
essential for cell proliferation.
To determine the stage of the cell cycle at which SP600125 may 
act to block cell proliferation, the DNA content of SP600125-treated 
IMR90 cells was analyzed by flow cytometry. Since IMR90 cells 
complete one cycle in roughly 24 hrs, analyses were performed at 24, 
48 and 72 hr after SP600125 treatment. In control cultures, more 
than 80% of the cells contained 2N (G1/S) DNA content. However, 
the majority (~80%) of SP600125-treated cells had 4N (G2/M) 
DNA content at all time points examined (Fig. 1C). These results 
suggest that the inhibition of basal JNK activity may block prolifera-
tion by causing sustained cell cycle arrest at G2/M.
To determine the precise stage of G2/M arrest in SP600125-treated 
cells, we examined Cdc2 activation and cyclin A degradation in these 
cells. In mammalian cells, Cdc2 is activated at the beginning of mitosis 
via dephosphorylation at Y15.18 Cyclin A becomes degraded in early 
mitosis after the nuclear envelope has broken down.19 In our experi-
ments, IMR90 cells were synchronized in G1/S by double thymidine 
arrest and SP600125 was added 5.5–6 hr after the release, when the cells 
were mainly in G2 (verified by FACS, data not shown), to exclude the 
potential effects of JNK inhibition to other cell cycle stages. SP600125-
treated cells showed a significant delay in Cdc2 dephosphorylation and 
cyclin A degradation, while both events were apparent at 10 hr after 
release in control cells. These observations indicate that JNK activity is 
necessary for mitotic entry in unstressed cells (Fig. 1D).
Histone H3 phosphorylation at S10 is a well documented marker 
of late G2 and early M for the initiation of chromosome condensa-
tion.1 To further validate this finding that mitotic entry is delayed by 
inhibition of basal JNK activity, we tested the effect of SP600125 on 
histone H3 phosphorylation at S10. We also examined the effect of 
SP600125 on the nuclear translocation of cyclin B1, which occurs 
prior to nuclear envelope break down (NEBD) and is considered to 
be an early marker of mitotic entry.20 IMR90 cells were synchro-
nized, released for 5.5 hrs, treated with 20 μM SP600125 or DMSO 
for 1.5 hrs, and co-immunostained with antibodies against cyclin B1 
and phosphorylated histone H3 (pH3) at S10. In control cells, the 
intensity of pH3 staining roughly correlated with the localization of 
cyclin B1: weak pH3 staining (G2 phase) correlated with cytoplasmic 
cyclin B1, moderate pH3 staining (early prophase) correlated with 
both cytoplasmic and nuclear cyclin B1, and strong pH3 staining 
(late prophase) with nuclear cyclin B1 (Fig. 1E, left).17 Most of 
the control cells exhibiting cyclin B1 nuclear translocation showed 
either moderate or strong pH3 staining (Fig. 1E, graph). However, 
most SP600125-treated cells showed little to no pH3 staining under 
these conditions with cyclin B1 being dispersed throughout the cyto-
plasm. These results support the finding that inhibition of basal JNK 
activity blocks mitotic entry and they strongly suggest that, during 
G2/M transition, JNK activity is directly correlated with histone H3 
phosphorylation at S10.
G2/M cell cycle arrest by SP600125 was also confirmed in mouse 
nontransformed fibroblast NIH3T3 cells. When NIH3T3 cells were 
synchronized, released and treated with SP600125, very few pH3-
positive cells were observed. This implies that the function of basal 
JNKs during G2/M transition may not be cell-type specific (Fig. 1F).
Basal JNK activity is necessary for histone H3 phosphoryla-
tion during G2/M phase. In previous experiments, we mainly 
used SP600125 to selectively block the activity of JNKs. However, 
SP600125 has been reported to inhibit global histone H3-S10 phos-
phorylation independently of JNK pathways.21 Therefore, to confirm 
that the inhibition of histone H3 phosphorylation observed in Figure 
1E was due to the inhibition of JNKs, rather than SP600125 itself, 
we examined histone H3 phosphorylation in the presence of other 
JNK-specific inhibitors, JNK inhibitor I and JNK inhibitor III. JNK 
inhibitor I blocks JNK signaling by preventing interactions between 
JNK and JNK-interacting protein-1 (JIP-1).22 JNK inhibitor III 
selectively disrupts c-Jun/JNK complex formation and consequently, 
activation of c-Jun.23 To further confirm whether the inhibition of 
histone H3-S10 phosphorylation is specifically due to the inhibi-
tion of JNKs, we examined histone H3-S10 phosphorylation in the 
presence of selective p38 inhibitor, SB203580. IMR90 cells were 
synchronized, released for 5.5 hrs, and incubated with SP600125, 
JNK inhibitor I, JNK inhibitor III, SB203580, or DMSO for 1.5 
hrs. As shown in Figure 2A, both JNK inhibitor I and inhibitor III 
decreased the number of pH3-positive cells, although inhibitor I was 
less effective than inhibitor III. Both inhibitors were also less effec-
tive than SP600125 (Fig. 2A). These differences in efficacy are likely 
based on the mechanism of each inhibitor.22,23 Although both JNKs 
and p38 are stress-activated protein kinases (SAPKs), SB203580-
treated cells did not exhibit any decrease in mitotic histone H3-S10 
phosphorylation compared to control cells (Fig. 2A). Taken together, 
these observations demonstrate that basal JNKs specifically control 
histone H3-S10 phosphorylation during G2/M phase.
To test whether JNKs are responsible for histone H3 phosphory-
lation at G2/M phase, we measured histone H3-S10 phosphorylation 
in the presence and absence of JNK inhibitors by immunoblotting. 
IMR90 cells were synchronized by double thymidine arrest, released 
for 5.5 hrs, and treated with SP600125 or JNK inhibitor III for 1.5 
or 3.5 hrs (i.e., 7 or 9 hr after the release). Inhibition of JNK activity 
by SP600125 or JNK inhibitor III was confirmed by immunoblot-
ting with anti-p-JNK/SAPK antibody (Fig. 2B). Neither inhibitor 
affected the expression of JNKs (data not shown). In control cells, 
histone H3-S10 phosphorylation increased from 1.5 to 3.5 hrs (Fig. 
2B). However, the phosphorylation of histone H3-S10 was not 
observed both in SP600125-treated cells (at both time points) and in 
the JNK inhibitor III-treated cells (at 3.5 hr; Fig. 2B).
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Figure 1. SP600125 inhibits cell proliferation and induces G2/M cell cycle arrest. (A) Effects of SP600125 (20 μM), JNK inhibitor I (10 μM) and JNK 
inhibitor III (10 μM) on the proliferation of IMR90 cells. Data are shown as the mean (±SD) of three independent experiments. (B) Effect of the knock-down 
of JNK1 and 2 by RNAi on the proliferation of IMR90 cells. Depletion of JNK/SAPK expression was evaluated by immunoblots after RNAi oligonucleotides 
transfected cells were incubated for 48 or 72 hrs (right). (C) Effect of SP600125 (20 μM) on cell cycle progression, as measured by flow cytometric analysis. 
The fraction of cells with 2N and 4N DNA content is indicated. (D–F) G2/M arrest by SP600125. IMR90 or NIH3T3 cells were treated with SP600125 (20 
μM) following synchronization by double thymidine arrest and release for 5.5–6 hrs. (D) Immunoblot analysis for cyclin A, phosphorylated Cdc2 (Y15), and 
actin (loading control). (E) Immunofluorescence microscopy for Ser-10-phosphorylated histone H3 (pH3) and cyclin B1 performed 1.5 hr after SP600125 
exposure (Scale bar, 10 μm). Nuclei were counterstained with DAPI. (E, graph) The number of pH3-positive cells was counted and sorted based on pH3 
fluorescence intensity (W, weak; M, moderate; S, strong) and on the location of cyclin B1 (C, cytoplasm; CN, cytoplasm and nucleus; N, nucleus). Only 
cells in G2 or prophase prior to nuclear envelope breakdown were counted. (F) The percent of pH3-positive cells following treatment of IMR90 or NIH3T3 
cultures with SP600125 for 1.5 hr and immunostaining with anti-pH3 antibody and DAPI. For each condition, 200 cells were counted, and the percentage 
of pH3-positive cells was determined from the total number of DAPI-stained cells. Data represent the mean (±SD) of three independent experiments.
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To further verify these results, we examined the effect of domi-
nant negative (DN) JNK1 or 2 on histone H3-S10 phosphorylation 
in IMR90 cells. Immunoblotting was performed to confirm the 
expression of DN-JNK1 (data not shown) and DN-JNK2 (Fig. 2C). 
As shown in Figure 2C, the number of pH3-positive cells in DN-
JNK1- or DN-JNK2-transfected cultures was much lower than that 
in control (untransfected) cultures.
The control of histone H3 phosphorylation by basal JNKs at the 
G2/M was also verified in cells where the expression of JNK1 and 2 
was knocked down by RNAi. 72 hrs after the RNAi oligonucleotides 
were transfected, the expression of JNK1 and 2 was vastly diminished 
as shown by an immunoblot (Fig. 2D). In these cells, the histone H3 
phosphorylation at S10 was decreased (Fig. 2D). These results by the 
block of basal JNK activity using dominant negative JNKs or RNAi 
Figure 2. JNK inhibition blocks the phosphorylation of histone H3 at serine 10. (A and B) IMR90 cells were synchronized by double thymidine arrest, 
released for 5.5 hrs (t = 5.5), and treated with SP600125 (20 μM), JNK inhibitor I (10 μM), JNK inhibitor III (10 μM), SB203580 (20 μM), or DMSO as 
indicated. (A) Cells were treated with each inhibitor for 1.5 hrs and processed for Ser-10-phosphorylated histone H3 (pH3) immunofluorescence staining. 
The mean (±SD) percentage of pH3-positive cells was determined in three independent experiments, based on the total number of DAPI-stained cells. (B) 
Immunoblot analysis of pH3, histone H3, and phosphorylated JNK/SAPK. (C) IMR90 cells transfected with DN-JNK1 or DN-JNK2 were synchronized as 
described in Materials and Methods, released for 7 hr, and processed for pH3 immunofluoresence staining. Expression of DN-JNK2 was confirmed by 
anti-Myc immunoblotting. (D) IMR90 cells where the expression of JNK1 and 2 was knocked down by RNAi as described in Materials and Methods, were 
immunostained with pH3 and DAPI. JNK/SAPK depletion was shown by an immunoblot (lower). (C and D) The mean percentage (±SD) of pH3-positive 
cells was determined as in (A). (E) In vitro kinase assay of JNKs immunoprecipitated from the cells synchronized by double thymidine arrest and released 
for 7 hrs. Kinase activity was assayed in the presence or absence of 20 μM SP600125. 32P-labeled histone H3 was detected by autoradiography (upper). 
Immunoprecipitated JNKs were detected by immunoblot (lower).
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are consistent with those obtained by using selective JNK inhibi-
tors, and demonstrate that basal JNK1/2 regulates mitotic entry by 
controlling histone H3-S10 phosphorylation.
We then checked whether JNKs can directly phosphorylate 
histone H3 in vitro. IMR90 cells at G2/M phase were obtained by 
double thymidine arrest and release for 7 hrs. JNKs immunoprecipi-
tated from these cells were then assayed for kinase activity. The result 
revealed that JNKs purified from G2/M cells directly phosphorylated 
histone H3 (Fig. 2E). Moreover, this phosphorylation was completely 
inhibited in the presence of SP600125 (Fig. 2E).
Basal JNKs become activated and directly interact with histone 
H3 at G2/M phase. Our data up to now showed that basal JNKs 
promote mitotic progression by controlling histone H3 phosphory-
lation during the G2/M phase of the cell cycle. To further prove the 
function of basal JNKs for mitotic entry, we investigated whether 
basal JNK1/2 becomes activated, independently of any stresses, 
during cell cycle progression. We observed that the phosphorylation 
and activation of basal JNKs is cell cycle-dependent. Immunoblot 
analysis of phosphorylated JNK1/2 revealed that these active forms 
of the protein were detected only between 7 and 9 hr after the release 
from double thymidine arrest, when most cells were in G2/M or 
M phase (Fig. 3A). Total levels of basal JNKs remained unaltered 
throughout the cell cycle (Fig. 3A).
In addition to immunoblot analysis, we performed immunofluo-
rescence staining of phosphorylated JNK1/2. Cells were co-stained 
for γ-tubulin, which served as a marker for centrosomes and provided 
a reference for each cell cycle stage. Consistent with immunoblot 
results, no phosphorylated JNK1/2 was detected in S phase (Fig. 3B). 
However, phosphorylated JNK1/2 began to localize to nuclei at late 
G2 phase. This localization became more intense in prophase, and in 
metaphase, phosphorylated JNK1/2 was concentrated at centrosomes 
(Fig. 3B). This pattern of localization during G2/M phase agrees well 
with the proposed function of JNK1/2 in promoting mitotic entry 
via histone H3 phosphorylation. It is also consistent with the local-
ization of other mitotic kinases that have been reported to control 
histone H3 phsophorylation. For example, NIMA and aurora A 
kinases have been shown to be present in the nucleus during late G2 
and concentrated at centrosomes in early mitosis.4,24 Also, aurora B 
kinase has been shown to co-localize with the phosphorylated form 
of histone H3.25
The localization of basal JNKs to the nucleus and centrosomes 
at G2/M phase as well as their ability to phosphorylate histone 
H3 in vitro led us to examine whether JNKs directly interact with 
histone H3 in vivo to control mitotic entry. To do this experiment, 
IMR90 cells were synchronized by double thymidine arrest and 
released for either 2 hrs (S-Phase) or 7 hrs (G2/M-Phase). JNKs or 
phosphorylated histone H3 were immunoprecipitated from these 
cells and then probed for histone H3 or p-JNK/SAPK, respectively. 
Histone H3 co-immunoprecipitated with JNKs and, in reverse, 
phosphorylated form of JNKJ/SAPK co-immunoprecipitated with 
phosphorylated histone H3 in cells that had been released for 7 hrs, 
but not in those released for 2 hrs (Fig. 3C). To understand whether 
Figure 3. Cell cycle-dependent activation and localization of basal JNKs. (A) IMR90 cells synchronized by double thymidine arrest, harvested at the indicated 
time after release, and lysates were subjected to immunoblot analysis for phosphorylated and total JNK/SAPK. (B) Alternatively, to observe the localization of 
phosphorylated JNK1/2 at various stages of the cell cycle, cells were processed for immunofluorescence staining of phosphorylated JNK1/2 and γ-tubulin. 
(Scale bar, 10 μm) (C) Cells released for 1.5 or 6.5 hrs were exposed to osmotic stress (300 mM sorbitol) for 30 min or left untreated (thus, 2 or 7 hr after 
the release in each case). From these cells, JNK/SAPK was immunoprecipitated and probed for histone H3 (upper) and, in reverse, pH3 was immunopre-
cipitated and probed for p-JNK/SAPK (lower) in western blots. Immunoprecipitation using anti-β-actin antibody served as a negative control.
©2
008
 LA
ND
ES 
BIO
SCI
EN
CE.
 DO
 NO
T D
IST
RIB
UT
E.
JNKs promote mitosis through H3 phosphorylation
www.landesbioscience.com Cell Cycle 221
the stress-induced JNK activation alters this pattern of JNK-histone 
H3 interactions, we repeated these co-precipitation experiments in 
cells that had been treated with 300 mM sorbitol for 30 min to 
activate JNK/SAPK by osmotic stress. The results were identical to 
those obtained in non-stressed cells (Fig. 3C).
Discussion
JNKs are well-known for their ability to induce immediate-
early gene expression in response to various extracellular stresses 
through histone H3 phosphorylation at S10. In this study, we have 
demonstrated a novel function of basal JNKs, which is separate 
from that of the stress-activated protein. Our data reveal that, in 
primary IMR90 cells, basal JNKs function at G2/M phase to control 
histone H3 phosphorylation at S10 for mitotic onset. Previously, 
several studies have provided clues as to the function of JNKs in 
cell cycle regulation. For example, inactivation of MKK7 is lethal to 
mouse embryos, and MKK7-/-  mouse embryonic fibroblasts (MEFs) 
exhibit impaired proliferation as well as G2/M cell cycle arrest.
14 
Also, inhibition of basal JNK activity in several cancer cell lines 
leads to G2/M arrest.
15,16 Nonetheless, the mechanism by which 
JNKs control cell cycle progression and especially the G2/M transi-
tion is not well understood. Our findings are consistent with these 
studies and strongly support a role for basal JNKs in promoting cell 
cycle progression and proliferation. Moreover, our results provide a 
possible mechanism by which JNKs promote G2/M transition.
Although some studies have suggested that basal JNKs may play 
a role in cell proliferation,15,16 the function of JNK signaling in 
the proliferation of cancer cell lines is controversial. For example, 
Kennedy et al. have shown that JNK1/2 attenuates cell proliferation 
after NIH3T3 cells are transformed by Ras.26 We reasoned that, in 
transformed cell lines, mutations in oncogenic pathways may affect 
signaling pathways responsible for basal JNK activity. Thus, to 
understand the role of basal JNKs in cell cycle progression, we chose 
to study early-passage, non-transformed IMR90 cells in the absence 
of extracellular stress. In these cells, the role of JNKs in promoting 
mitotic entry via histone H3 phosphorylation is evident. However, 
the effect of JNKs on mitotic entry might vary in transformed cells 
depending on the genetic background of each cell line.
Our results clearly show that JNKs become activated only at 
G2/M phase and that inhibition of JNK activity blocks histone H3-
S10 phosphorylation. Although our data reveal that JNKs promote 
mitotic entry by phosphorylating histone H3, it is unclear if this 
phosphorylation event is direct or indirect. The fact that basal 
JNKs co-precipitate with H3 as well as the phosphorylated H3 co-
precipitates with the phosphorylated active form of JNK/SAPK in 
cells exclusively at G2/M phase and that basal JNKs from the cells 
at the G2/M are able to directly phosphorylate H3 in vitro, suggest 
that basal JNKs directly interact with and phosphorylate histone H3 
during G2/M phase. Nevertheless, JNKs are localized to nuclei at late 
G2 phase and in centrosomes at early mitotic stages. This cell cycle-
dependent pattern of localization mirrors that of NIMA and aurora 
kinases, which are known to phosphorylate histone H3 for mitotic 
entry. Based on this, we cannot exclude the possibility that basal JNKs 
control H3 phosphorylation through NIMA and/or aurora kinases. 
Additional studies will be necessary not only to clarify this question, 
but also to elucidate the signaling pathway(s) that mediate activation 
of JNKs at G2/M phase and ultimately, control mitotic entry.
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